Literature DB >> 16429918

Harmonic contrast transesophageal echocardiography of a soft-parts sarcoma metastatic to the heart.

Shun Kohsaka1, Vaporaciyan Ara, Sayed F Feghali, Raymond F Stainback.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16429918      PMCID: PMC1351845     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


× No keyword cloud information.
  4 in total

1.  ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography).

Authors:  Melvin D Cheitlin; William F Armstrong; Gerard P Aurigemma; George A Beller; Fredrick Z Bierman; Jack L Davis; Pamela S Douglas; David P Faxon; Linda D Gillam; Thomas R Kimball; William G Kussmaul; Alan S Pearlman; John T Philbrick; Harry Rakowski; Daniel M Thys; Elliott M Antman; Sidney C Smith; Joseph S Alpert; Gabriel Gregoratos; Jeffrey L Anderson; Loren F Hiratzka; Sharon Ann Hunt; Valentin Fuster; Alice K Jacobs; Raymond J Gibbons; Richard O Russell
Journal:  Circulation       Date:  2003-09-02       Impact factor: 29.690

2.  Differential diagnosis of cardiac masses using contrast echocardiographic perfusion imaging.

Authors:  James N Kirkpatrick; Tiffany Wong; James E Bednarz; Kirk T Spencer; Lissa Sugeng; R Parker Ward; Jeanne M DeCara; Lynn Weinert; Thomas Krausz; Roberto M Lang
Journal:  J Am Coll Cardiol       Date:  2004-04-21       Impact factor: 24.094

Review 3.  Primary and secondary neoplasms of the heart.

Authors:  W C Roberts
Journal:  Am J Cardiol       Date:  1997-09-01       Impact factor: 2.778

4.  Assessment of the vascularity of a left ventricular mass using myocardial contrast echocardiography.

Authors:  Wolfgang Lepper; Bharati Shivalkar; Diana Rinkevich; Todd Belcik; Kevin Wei
Journal:  J Am Soc Echocardiogr       Date:  2002-11       Impact factor: 5.251

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.